These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Diabetes mellitus--diagnosis and blood glucose control]. Elke B, Käser L, Berneis K, Spinas G, Battegay E. Praxis (Bern 1994); 2008 May 14; 97(10):529-37; quiz 538-9. PubMed ID: 18595368 [No Abstract] [Full Text] [Related]
5. [Intensive blood glucose reduction: yes or no?]. Bischoff A. MMW Fortschr Med; 2015 Mar 05; 157(4):18-9. PubMed ID: 25743962 [No Abstract] [Full Text] [Related]
6. Intensified glucose control in type 2 diabetes--whose agenda? Yudkin JS, Richter B, Gale EA. Lancet; 2011 Apr 09; 377(9773):1220-2. PubMed ID: 21093903 [No Abstract] [Full Text] [Related]
7. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk. Wareham NJ, Pfister R. Nat Rev Cardiol; 2010 Jul 09; 7(7):367-8. PubMed ID: 20577298 [Abstract] [Full Text] [Related]
8. [Diabetology 2010]. Martin S. Dtsch Med Wochenschr; 2010 Jun 09; 135(25-26):1299-301. PubMed ID: 20556686 [No Abstract] [Full Text] [Related]
9. Clinical practice. Glycemic management of type 2 diabetes mellitus. Ismail-Beigi F. N Engl J Med; 2012 Apr 05; 366(14):1319-27. PubMed ID: 22475595 [No Abstract] [Full Text] [Related]
10. [Critical questions on diabetes therapy and their sequelae. HbA1c: may it be more than 7 after all?]. Aumiller J. MMW Fortschr Med; 2009 Oct 15; 151(42):14-6. PubMed ID: 19938773 [No Abstract] [Full Text] [Related]
11. Management of Type 2 Diabetes in 2017: Getting to Goal. Reusch JE, Manson JE. JAMA; 2017 Mar 14; 317(10):1015-1016. PubMed ID: 28249081 [No Abstract] [Full Text] [Related]
12. [Hypoglycemia--simply annoying or dangerous?]. Kern W. MMW Fortschr Med; 2016 Jun 09; 158(11):67-70. PubMed ID: 27271419 [No Abstract] [Full Text] [Related]
13. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes. Mannucci E, Monami M, Ceriello A, Rotella CM. Nutr Metab Cardiovasc Dis; 2017 Apr 09; 27(4):375-377. PubMed ID: 28242233 [No Abstract] [Full Text] [Related]
14. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines]. Adler AI, Shaw EJ, Stokes T, Ruiz F. Praxis (Bern 1994); 2009 Oct 07; 98(20):1161-3. PubMed ID: 19809980 [No Abstract] [Full Text] [Related]
15. [Lowering blood glucose has little effect: myth or fact?]. Stiefelhagen P. MMW Fortschr Med; 2015 Nov 19; 157(20):14. PubMed ID: 26977492 [No Abstract] [Full Text] [Related]
16. Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control. Bloomgarden Z. J Diabetes; 2017 Aug 19; 9(8):722-723. PubMed ID: 28513098 [No Abstract] [Full Text] [Related]
17. [Rapid disease progression, early insulin requirement]. Einecke D. MMW Fortschr Med; 2012 Jun 28; 154(12):26. PubMed ID: 22880292 [No Abstract] [Full Text] [Related]
18. Guidelines ease up on glycemic control for some patients with type 2 diabetes. Mitka M. JAMA; 2012 Jun 06; 307(21):2243-4. PubMed ID: 22706812 [No Abstract] [Full Text] [Related]
19. [Diabetes in old age--risk by over- and undertreatment]. Zeyfang A, Bahrmann A. MMW Fortschr Med; 2013 Jul 25; 155(13):56-8. PubMed ID: 23964510 [No Abstract] [Full Text] [Related]
20. [Insulin therapy of type 2 diabetes: from simple to flexible--three strategies are available]. Liebl A. MMW Fortschr Med; 2012 Nov 08; 154 Spec No 3():66-71; quiz 72-3. PubMed ID: 23724722 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]